
ProQR Therapeutics N.V. PRQR
$ 1.36
1.49%
ProQR Therapeutics N.V. PEG Ratio | PRQR
Annual PEG Ratio ProQR Therapeutics N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.312 | 0.206 | 0.542 | 0.216 | 0.123 | -1.52 | -1.53 | 0.32 | -0.664 | -0.0237 | 0.274 | -0.0241 | - | - | - |
Annual performance
Select metrics to display
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.542 | -1.53 | -0.147 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Evogene Ltd.
EVGN
|
-0.00649 | $ 0.28 | -16.14 % | $ 2.2 M | ||
|
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | ||
|
Protara Therapeutics
TARA
|
0.264 | $ 2.33 | 9.15 % | $ 99.8 M | ||
|
Trevi Therapeutics
TRVI
|
1.94 | $ 14.33 | 11.87 % | $ 1.93 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-0.00342 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Fennec Pharmaceuticals
FENC
|
0.000178 | $ 9.79 | 4.26 % | $ 280 M | ||
|
Kiromic BioPharma
KRBP
|
-0.00492 | - | 6.61 % | $ 3.08 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.000003 | $ 3.92 | -2.24 % | $ 1.74 M | ||
|
Calithera Biosciences
CALA
|
-0.00162 | - | -10.95 % | $ 876 K | ||
|
United Therapeutics Corporation
UTHR
|
0.805 | $ 562.14 | -0.63 % | $ 24.9 B | ||
|
Vericel Corporation
VCEL
|
-0.889 | $ 54.56 | 5.36 % | $ 2.75 B | ||
|
Veracyte
VCYT
|
1.03 | $ 24.1 | 0.42 % | $ 1.89 B | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Fulcrum Therapeutics
FULC
|
-0.000402 | $ 3.72 | 0.95 % | $ 236 M | ||
|
Molecular Templates
MTEM
|
-0.00416 | - | -23.43 % | $ 495 K | ||
|
Vanda Pharmaceuticals
VNDA
|
-0.0515 | $ 3.82 | 6.27 % | $ 225 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-0.0249 | $ 3.22 | 4.21 % | $ 34.3 M | ||
|
Viridian Therapeutics
VRDN
|
0.582 | $ 28.47 | -0.28 % | $ 2.9 B | ||
|
BioXcel Therapeutics
BTAI
|
-0.000761 | $ 0.07 | 9.81 % | $ 855 K | ||
|
VistaGen Therapeutics
VTGN
|
-0.0036 | $ 0.17 | 3.45 % | $ 6.47 M | ||
|
Voyager Therapeutics
VYGR
|
0.0127 | $ 1.86 | 8.14 % | $ 109 M | ||
|
CohBar
CWBR
|
-0.000901 | - | -15.44 % | $ 2.2 M | ||
|
NeuBase Therapeutics
NBSE
|
0.00351 | - | -1.56 % | $ 12.3 M | ||
|
Gossamer Bio
GOSS
|
-0.103 | $ 9.77 | 3.72 % | $ 2.23 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
-1.67 | - | - | $ 2.18 B | ||
|
GeoVax Labs
GOVX
|
-0.000282 | $ 0.16 | -5.0 % | $ 153 K | ||
|
Arena Pharmaceuticals
ARNA
|
-0.000409 | - | -6.81 % | $ 3.04 B | ||
|
Scopus BioPharma
SCPS
|
0.036 | - | -48.37 % | $ 3.71 M | ||
|
Annovis Bio
ANVS
|
-0.0518 | $ 0.82 | 23.72 % | $ 16.9 M | ||
|
scPharmaceuticals
SCPH
|
-2.51 | - | - | $ 218 M | ||
|
Xeris Pharmaceuticals
XERS
|
-26.7 | $ 15.08 | 15.29 % | $ 2.42 B | ||
|
X4 Pharmaceuticals
XFOR
|
-0.0109 | $ 3.15 | 2.61 % | $ 133 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
0.123 | - | - | $ 105 M | ||
|
Athersys
ATHX
|
-0.000135 | - | 3.77 % | $ 22.4 M | ||
|
Zai Lab Limited
ZLAB
|
57.7 | $ 25.49 | 12.77 % | $ 27.9 B | ||
|
Zentalis Pharmaceuticals
ZNTL
|
0.137 | $ 1.71 | 2.05 % | $ 123 M | ||
|
Zoetis
ZTS
|
6.1 | $ 79.51 | -3.21 % | $ 35.3 B | ||
|
Global Blood Therapeutics
GBT
|
-0.422 | - | - | $ 4.62 B | ||
|
Inozyme Pharma
INZY
|
-0.0361 | - | - | $ 207 M | ||
|
Idera Pharmaceuticals
IDRA
|
-0.000442 | - | -23.04 % | $ 26.6 M | ||
|
NanoString Technologies
NSTG
|
-0.154 | - | -37.43 % | $ 5.1 M | ||
|
Humanigen
HGEN
|
-0.00141 | - | -81.12 % | $ 4.28 M | ||
|
Sorrento Therapeutics
SRNE
|
0.018 | - | -29.58 % | $ 126 M | ||
|
Surface Oncology
SURF
|
0.0307 | - | - | $ 59.7 M | ||
|
GlaxoSmithKline plc
GSK
|
4.02 | $ 50.28 | -0.27 % | $ 204 B | ||
|
Sierra Oncology
SRRA
|
-0.00778 | - | -0.05 % | $ 1.34 B | ||
|
Cocrystal Pharma
COCP
|
-0.00606 | $ 1.03 | 2.95 % | $ 11.6 M | ||
|
Atea Pharmaceuticals
AVIR
|
0.0231 | $ 4.27 | 1.18 % | $ 348 M | ||
|
Vaccinex
VCNX
|
-0.000064 | - | -61.37 % | $ 654 K | ||
|
ImmuCell Corporation
ICCC
|
0.153 | $ 9.9 | -0.5 % | $ 89.4 M |